(Q37170615)

18 August 2017

1 reference

title

Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs (English)

1 reference

18 August 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

9 December 2022

author name string

R. J. MacFadyen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849731

9 December 2022

K. R. Lees

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849731

9 December 2022

J. L. Reid

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849731

9 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

PMC publication ID

1368406

full work available at URL

18 August 2017

https://europepmc.org/articles/PMC1368406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849731

https://europepmc.org/articles/PMC1368406?pdf=render

9 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1849731

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1991.tb03851.x

9 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1991.tb03851.x/fullpdf

9 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

British Journal of Clinical Pharmacology

9 December 2022

published in

1 reference

18 August 2017

31

1 reference

18 August 2017

1

1 reference

18 August 2017

1-13

1 reference

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Fate of angiotensin I in the circulation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Intravenous captopril treatment in patients with severe cardiac failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin converting enzyme inhibitors and ischaemic heart disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The acute haemodynamic effects of intravenous enalaprilic acid (MK422) in patients with left ventricular dysfunction

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Circulating and tissue angiotensin systems

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Significance of the vascular renin-angiotensin pathway

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Severe hypotension after first dose of enalapril in heart failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Antihypertensive treatment according to age, plasma renin and race

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Treatment of chronic heart failure: a review of recent drug trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Lung angiotensin converting enzyme activity in rats with differing susceptibilities to chronic hypoxia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Diurnal variation of pulmonary artery pressure in chronic heart failure

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Pharmacokinetics of angiotensin converting enzyme inhibitors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Estimation of regional metabolism and production of angiotensins in hypertensive subjects

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The effects of intradermal bradykinin are potentiated by angiotensin converting enzyme inhibitors in hypertensive patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Short- and long-acting angiotensin-converting enzyme inhibitors: a randomized trial of lisinopril versus captopril in the treatment of congestive heart failure. The Multicenter Lisinopril-Captopril Congestive Heart Failure Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Remodelling of the heart in response to chronic mechanical overload

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Vasodilator therapy without converting-enzyme inhibition in congestive heart failure--usefulness and limitations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The peculiar characteristics of the amino acid sequence of angiotensin I-converting enzyme, as determined by cDNA cloning of the human endothelial enzyme.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

A review of the renin-angiotensin system in the normal heart

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin-converting enzyme: new concepts concerning its biological role

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Short term haemodynamic effects of converting enzyme inhibition before and after eating in patients with moderate heart failure caused by dilated cardiomyopathy: a double blind study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

A simple radioassay for angiotensin-converting enzyme

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Localization of angiotensin converting enzyme (kininase II). II. Immunocytochemistry and immunofluorescence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Vascular renin-angiotensin system: the unanswered questions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin inhibitors and other vasodilators with special reference to congestive heart failure

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Tissue renin-angiotensin systems aspects of molecular biology and pharmacology

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Metabolic functions of the pulmonary vascular endothelium

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The Brain Renin-Angiotensin System

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Haemodynamic Responses to Specific Renin-Angiotensin Inhibitors in Hypertension and Congestive Heart Failure A Review

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Metabolic functions of the pulmonary circulation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin I converting enzyme

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Immunochemical comparison of angiotensin 1 converting enzymes from different rat organs

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin Convertase Activities in Human Alveolar Macrophages: Effects of Cigarette Smoking and Sarcoidosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Induction of angiotensin converting enzyme in human monocytes in culture

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Immediate converting-enzyme inhibition with intravenous enalapril in chronic congestive heart failure

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The isolation of angiotensin-converting enzyme cDNA.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Lavage angiotensin-converting enzyme as a marker of lung injury

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Assay of peptidase and protease enzymes in vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Concentration effect modelling with converting enzyme inhibitors in man.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Distribution of Angiotensin-Converting Enzyme Activity in Specific Areas of the Rat Brain Stem

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin-converting enzyme: I. New strategies for assay

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Hemodynamic changes mimicking a vasodilator drug response in the absence of drug therapy after right heart catheterization in patients with chronic heart failure.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Effects of eating on cardiac performance in congestive heart failure.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin II binding sites in the conduction system of rat hearts.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Characterization of angiotensin converting enzyme by [3H]captopril binding

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Kinetics of captopril- and enalapril-induced inhibition of pulmonary angiotensin converting enzyme in vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

A rat brain isozyme of angiotensin-converting enzyme. Unique specificity for amidated peptide substrates

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

An angiotensin converting enzyme inhibitor is a tight-binding slow substrate of carboxypeptidase A.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

A survey of current use of angiotensin-converting-enzyme inhibitors by Scottish physicians in the treatment of chronic cardiac failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Role of renin-angiotensin system in the pathogenesis of spontaneous myocardial fibrosis in Sprague-Dawley rats: effect of long-term administration of captopril

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Hydrolysis of a synthetic angiotensin-converting enzyme substrate in dog lungs.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin converting enzyme activity is present in the endothelium-denuded aorta

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin-converting enzyme as a possible marker for lung toxicity in amiodarone-treated patients.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin converting enzyme in the rat heart: studies of its inhibition in vitro and ex vivo

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Kinetic and inhibitory characteristics of serum angiotensin-converting enzyme from nine mammalian species

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The influence of prostaglandin inhibition by indomethacin on blood pressure and renal function in hypertensive patients treated with cilazapril

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin facilitation of 3H-norepinephrine release in central tissue of spontaneously hypertensive rats but not in Wistar-Kyoto rats: effects of sodium depletion.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Local formation of angiotensin II in the rat aorta: effect of endothelium

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Metabolism of tetradecapeptide, angiotensinogen and angiotensin I and II by isolated perfused rat hindlimbs.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Substrate-dependent angiotensin II formation in the peripheral circulation.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

3 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03851.X

Renin: endocrine, paracrine, or part-paracrine control of blood pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03851.X

Clinical trials in congestive heart failure: why do studies report conflicting results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03851.X

Comparative regional distribution of angiotensin-I-converting enzyme in the rat, rabbit, dog, monkey and human kidneys

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368406

Hydrolysis of angiotensin I by peptidases in homogenates of rat lung and aorta

20 October 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03851.X

Affinity chromatography and some properties of the angiotensin-converting enzyme from human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03851.X

Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat

21 January 2018

1 reference

12 December 2020

ACE Inhibition with Cilazapril Improves Myocardial Perfusion to the Ischemic Regions During Exercise

1 reference

12 December 2020

Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure

1 reference

12 December 2020

Transpulmonary angiotensin II formation in patients with chronic stable cor pulmonale

1 reference

12 December 2020

Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron

1 reference

12 December 2020

The relationship between serum enalaprilat concentration and the hypotensive effect in man

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in plasma and tissues

1 reference

12 December 2020

Suppression of renin-angiotensin system in the heart of spontaneously hypertensive rats

1 reference

12 December 2020

Tissue renin-angiotensin systems: focus on the heart

1 reference

12 December 2020

Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics

1 reference

12 December 2020

Assay of angiotensin converting enzyme in vivo

1 reference

12 December 2020

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421

1 reference

12 December 2020

Captopril therapy for severe CHF: hypotensive response in presence of markedly elevated PRA

1 reference

12 December 2020

Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats

1 reference

12 December 2020

Induction of angiotensin I-converting enzyme in rat lung with captopril: The effect of adrenalectomy

1 reference

12 December 2020

Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats

1 reference

12 December 2020

Role of the kidney in congestive heart failure

1 reference

12 December 2020

Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498

1 reference

12 December 2020

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

1 reference

12 December 2020

Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses

1 reference

12 December 2020

Inhibitor binding assay for angiotensin-converting enzyme

1 reference

12 December 2020

Investigations of components of the renin-angiotensin system in rat vascular tissue

1 reference

12 December 2020

Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics

1 reference

12 December 2020

Hemodynamic results of perorally administered converting enzyme inhibitors in congestive heart failure

1 reference

12 December 2020

Pharmacokinetics of repeated single oral doses of enalapril maleate (mk-421) in normal volunteers

1 reference

12 December 2020

Kinetics of pulmonary angiotensin-converting enzyme and 5'-nucleotidase in vivo

1 reference

12 December 2020

Thermal denaturation of rat pulmonary and testicular angiotensin-converting enzyme isozymes. Effects of chelators and CoCl2

1 reference

12 December 2020

Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension

1 reference

12 December 2020

A transition-state analogue inhibitor of human renin (H.261): test in vitro and a comparison with captopril in the anaesthetized baboon

1 reference

12 December 2020

Local generation and release of angiotensin II in peripheral vascular tissue

1 reference

12 December 2020

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

12 December 2020

Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril

1 reference

12 December 2020

Alternative routes for angiotensin-I conversion: kinetics of the renin-angiotensin system in mouse plasma

1 reference

12 December 2020

Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement

1 reference

12 December 2020

Vasovagal reactions to cardiovascular drugs: the first dose effect

1 reference

12 December 2020

Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Cardiac renin-angiotensin system. Molecular and functional aspects

1 reference

12 December 2020

Measurement of immunoreactive angiotensin peptides in rat tissues: some pitfalls in angiotensin II analysis

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors

1 reference

12 December 2020

Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans

1 reference

12 December 2020

Studies on the angiotensin converting enzyme with different substrates

1 reference

12 December 2020

Intraoperative administration of the intravenous angiotensin-converting enzyme inhibitor, enalaprilat, in a patient with congestive heart failure

1 reference

12 December 2020

Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts

1 reference

12 December 2020

Ontogenesis of angiotensin-I converting enzyme in human Kidney

1 reference

12 December 2020

Intravenous captopril in acute heart failure

1 reference

12 December 2020

The kidney in hypertension--villain and victim

1 reference

12 December 2020

Effects of perindopril on tissue angiotensin-converting enzyme activity demonstrated by quantitative in vitro autoradiography

1 reference

12 December 2020

Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney

1 reference

12 December 2020

Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases

1 reference

12 December 2020

Role of endogenous bradykinins in the acute depressor effect of angiotensin converting enzyme inhibitor captopril--assessed by a competitive antagonist of bradykinin

1 reference

12 December 2020

Characteristics of monocyte angiotensin-converting enzyme (ACE) induction by dexamethasone

1 reference

12 December 2020

Arterial-venous determinations of the "immunoreactive" angiotensin peptides in human subjects

1 reference

12 December 2020

Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC-838) in spontaneously hypertensive rats

1 reference

12 December 2020

Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure

1 reference

12 December 2020

The NH2-and COOH-terminal sequences of the angiotensin-converting enzyme isozymes from rabbit lung and testis

1 reference

12 December 2020

Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase

1 reference

12 December 2020

Measurement of human converting enzyme level by direct radioimmunoassay

1 reference

12 December 2020

Reactive Hyperreninemia Is a Major Determinant of Plasma Angiotensin II During ACE Inhibition

1 reference

12 December 2020

Circulating and tissular renin-angiotensin systems

1 reference

12 December 2020

Assay of tissue angiotensin converting enzyme

1 reference

12 December 2020

Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes

1 reference

12 December 2020

Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man

1 reference

12 December 2020

NATURE OF THE INOTROPIC ACTION OF ANGIOTENSIN ON VENTRICULAR MYOCARDIUM

1 reference

12 December 2020

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

12 December 2020

The ventrolateral medulla. A new site of action of the renin-angiotensin system

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

Statine-containing renin inhibitor. Dissociation of blood pressure lowering and renin inhibition in sodium-deficient dogs

9 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

Opposite Effects of Captopril on Angiotensin I-Converting Enzyme ‘Activity’ and ‘Concentration’; Relation between Enzyme Inhibition and Long-Term Blood Pressure Response

9 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

9 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

Hemodynamic Results of Perorally Administered Converting Enzme Inhibitors in Congestive Heart Failure

9 December 2022

99

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03851.X

9 December 2022

Identifiers

1 reference

18 August 2017

1 reference

PMC publication ID

1368406

18 August 2017

1 reference

PMC publication ID

1368406